SCHEMBL25016197

SCHEMBL25016197

CCOC(=O)NC(=N)c1ccc2cc(C(=O)Nc3ccc(N4CCCC4)cc3)n(Cc3ccc(C(N)=O)cc3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 3/20 0.42
▸ MAPT P10636 11/20 0.42
▸ KMT2A Q03164 10/20 0.42
▸ ALDH1A1 P00352 6/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ RAB9A P51151 7/20 0.40
▸ MEN1 O00255 6/20 0.40
▸ NPC1 O15118 5/20 0.40
▸ USP2 O75604 3/20 0.40
▸ SMN1; SMN2 Q16637 8/20 0.39
▸ MCL1 Q07820 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ F2 P00734 1/20 0.38
▸ PRSS1 P07477 1/20 0.38
▸ HPGD P15428 4/20 0.38
▸ TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25016067 0.94 KMT2A (0.44) F10MAPTKMT2AALDH1A1ALOX15
SCHEMBL30180643 0.94 KMT2A (0.44) F10MAPTKMT2AALDH1A1ALOX15
SCHEMBL25017852 0.92 F10 (0.42) F10MAPTKMT2AALDH1A1ALOX15
SCHEMBL21822273 0.91 NPC1 (0.43) F10MAPTKMT2AALDH1A1ALOX15
SCHEMBL25015851 0.86 PLG (0.47) F10MAPTKMT2AALDH1A1ALOX15
SCHEMBL25015711 0.86 MAPT (0.39) F10MAPTKMT2AALDH1A1ALOX15
SCHEMBL25015847 0.85 PLG (0.47) F10MAPTKMT2AALOX15RAB9A
SCHEMBL25017853 0.85 F10 (0.42) F10MAPTF2PRSS1TP53
SCHEMBL30180630 0.85 F10 (0.42) F10MAPTF2PRSS1TP53
SCHEMBL25016774 0.85 MAPT (0.39) F10MAPTKMT2AALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 F10 1548/4885MAPT 1700/4885KMT2A 1072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback